Alessandro Rizzo,Enes Erul,Deniz Can Guven et al.
Alessandro Rizzo et al.
Introduction: Biliary tract cancer (BTC) is an aggressive cancer arising from biliary epithelial cells. The combination of immune checkpoint inhibitors (ICIs) with other anticancer therapies has recently emerged as a new ...
Correction [0.03%]
改正错误
Published Erratum
Expert review of clinical pharmacology. 2025 Nov 13:1. DOI:10.1080/17512433.2025.2587541 2025
Impact of gabapentinoids' reclassification policy and COVID-19 on gabapentinoids' utilization pattern and their associated mortality in Scotland and Northern Ireland: a segmental regression analysis [0.03%]
加巴喷丁类药物再分类政策和COVID-19对苏格兰和北爱尔兰加巴喷丁类药物使用模式及其相关死亡率的影响：分段回归分析
Abdullah Alrahmani,Mabast Azeez,Sahar Baker et al.
Abdullah Alrahmani et al.
Background: Gabapentinoids are commonly used for neuropathic pain but are increasingly linked with misuse/mortality. In 2019, the UK reclassified them as Schedule 3 controlled drugs. The onset of the COVID-19 pandemic cre...
A comprehensive systematic review of types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class [0.03%]
一项全面的系统回顾：减药工具涉及的药物种类以及适用于各类药物的工其/干预措施
Faisal Madanat,Solafa Noorsaeed,Rahaf Alkhlaifat et al.
Faisal Madanat et al.
Introduction: Polypharmacy and potentially inappropriate medications (PIMs) contribute to adverse outcomes. Deprescribing, the supervised withdrawal of PIMs, is a key strategy to reduce these risks. Identifying the most t...
Drug-drug interactions in anticoagulant therapy: a focus on oncology patients [0.03%]
抗凝治疗的药物相互作用：癌症患者为重点
Kristina Vrotniakaite-Bajerciene,Corey Tsang,Tzu-Fei Wang et al.
Kristina Vrotniakaite-Bajerciene et al.
Introduction: Patients with cancer are frequently exposed to polypharmacy, carrying a high risk of drug-drug interactions (DDIs). Given their substantial risk for thrombosis and atrial fibrillation, anticoagulants are com...
A pharmacological profile of somapacitan for the treatment of growth hormone deficiency [0.03%]
索马匹坦治疗生长激素缺乏症的药理学特征分析
Heba Al-Rayess,Bradley S Miller
Heba Al-Rayess
Introduction: Long-acting growth hormone (LAGH) preparations have been developed to reduce the burden of daily injections and improve compliance in children and adults with growth hormone deficiency (GHD). Somapacitan is ...
A review of current and emerging therapies in breast cancer: implications for older adults [0.03%]
乳腺癌当前和新兴疗法的综述：对老年患者的影响
Anna R Schreiber,Haydeé C Verduzco-Aguirre,Stephanie Giangiuli et al.
Anna R Schreiber et al.
Introduction: Breast cancer is the most common cancer in women. As global populations age, the number of older adults with breast cancer is expected to increase significantly. Recently, progress has been made across all s...
Clinical pharmacology of ayahuasca: potential applications and future considerations [0.03%]
亚叶素的临床药理：潜在应用及未来考虑因素
Lorena Terene Lopes Guerra,Isabella Caroline da Silva Dias,Jaime Eduardo Cecilio Hallak et al.
Lorena Terene Lopes Guerra et al.
Introduction: In the last few years, interest is growing around the topic of possible therapeutic properties of substances classified as psychedelic, especially for the treatment of mental disorders. Ayahuasca is a classi...
A pharmacological and clinical profile of Naxitamab for the treatment of high-risk neuroblastoma [0.03%]
纳西塔马布治疗高危神经母细胞瘤的药理和临床特征分析
Wei Wei,Shakeel I Modak
Wei Wei
Introduction: Naxitamab (previously named hu3F8) is a humanized monoclonal antibody(mAb) targeting disialoganglioside GD2, a ganglioside homogeneously and abundantly expressed on neuroblastoma and other neuroectodermal tu...
Difficult-to-treat psoriatic arthritis: challenges, mechanisms, and future directions [0.03%]
难治性银屑病关节炎：挑战、机制及未来方向
Rubén Queiro,Sara Alonso
Rubén Queiro